Report : Middle East & Africa Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles), Dermatology, Gynecology, Angiology, Orthopedics & Rheumatology, Sports Medicine, and Others], and End User (Hospitals, Aesthetic Clinics, and Wellness Center)
At 11.8% CAGR, the Middle East & Africa Carboxy Therapy Market is speculated to be worth US$ 7.09 million by 2028, says Business Market Insights
According to the Insight Partners’ research, the Middle East & Africa carboxy therapy market was valued at US$ 3.63 million in 2022 and is expected to reach US$ 7.09 million by 2028, registering a CAGR of 11.8% from 2022 to 2028. Increase in application areas and untapped potential of emerging economies are the critical factors attributed to the Middle East & Africa carboxy therapy market expansion.
The healthcare industry is constantly developing significantly due to the increasing prevalence of various disorders. Moreover, increasing awareness among people and changing beauty standards have increased the demand for aesthetics and beauty treatments which has increased the demand for various devices and treatments. When CO2 gas is injected into the body, it relaxes the blood vessels. It stimulates blood supply in that specific area by eliminating fat cells, which have shown impressive results in beauty and aesthetics. This has encouraged healthcare professionals to try carboxy therapy to treat various disorders in different areas, such as gynecology, neurology, urology, and sports medicine. For instance, carboxy therapy is widely used to treat vaginal insufficiency syndrome caused by reduced blood flow. Erectile dysfunction is also treated with the help of carboxy therapy nowadays. Moreover, carboxy therapy is one of the affordable treatment options which seems safe and effective, covering the broad therapeutic area, which is further expected to expand significantly in the near future. Moreover, the increase in application areas for carboxy therapy has created ample opportunities for carboxy therapy device manufacturers to develop and launch various devices, which further help deliver carboxy therapy. Thus, an increase in application areas of carboxy therapy, a surge in product launches, and further innovation in carboxy therapy devices are expected to promote the growth of the MEA carboxy therapy market during the forecast period.
On the contrary, regulatory policies and safety concerns associated with carbon therapy hurdles the growth of Middle East & Africa carboxy therapy market.
Based on type, the Middle East & Africa carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment held 47.3% share of Middle East & Africa carboxy therapy market in 2022, amassing US$ 1.71 million. It is projected to garner US$ 3.33 million by 2028 to expand at 11.7% CAGR during 2022–2028.
Based on application, the Middle East & Africa carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rehumatology, sports medicine, and others. The aesthetic medicine segment held 54.4% share of Middle East & Africa carboxy therapy market in 2022, amassing US$ 1.97 million. It is projected to garner US$ 3.84 million by 2028 to expand at 11.8% CAGR during 2022–2028. The aesthetic medicine segment is further subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles.
Based on end user, the Middle East & Africa carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment held 49.7% share of Middle East & Africa carboxy therapy market in 2022, amassing US$ 1.80 million. It is projected to garner US$ 3.50 million by 2028 to expand at 11.7% CAGR during 2022–2028
Based on country, the Middle East & Africa carboxy therapy market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 44.6% share Middle East & Africa carboxy therapy market in 2022. It was assessed at US$ 1.62 million in 2022 and is likely to hit US$ 3.10 million by 2028, exhibiting a CAGR of 11.5% during the forecast period.
Key players profiles in the Middle East & Africa carboxy therapy market report are Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; Mezopharma; and Nick Fanavaran Plasma Company, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com